SCHEMBL7037765

SCHEMBL7037765

Cc1ccccc1C(=S)c1ccc(Nc2nc3ccccc3s2)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.52
RAB9A P51151 9/20 0.52
SMN1; SMN2 Q16637 8/20 0.52
MAPT P10636 7/20 0.52
KMT2A Q03164 5/20 0.52
MEN1 O00255 4/20 0.52
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
GAA P10253 2/20 0.47
DHODH Q02127 1/20 0.47
NFKB1 P19838 4/20 0.46
NFKB2 Q00653 4/20 0.46
RELA Q04206 4/20 0.46
LMNA P02545 4/20 0.46
POLB P06746 4/20 0.46
MAPK13 O15264 2/20 0.45
MAPK12 P53778 2/20 0.45
MAPK11 Q15759 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7032075 0.87 MAPK13 (0.62) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL7040555 0.85 NPC1 (0.50) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL7037527 0.83 KMT2A (0.50) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL7037904 0.78 MAPK14 (0.46) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL1901734 0.77 MAPK14 (0.71) SMN1; SMN2MAPTKMT2AMEN1GAA
SCHEMBL1820681 0.77 SMN1; SMN2 (0.64) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL7032510 0.77 KDR (0.49) NPC1RAB9ASMN1; SMN2MAPTPOLB
SCHEMBL1899616 0.76 MAPK14 (0.61) SMN1; SMN2MAPTKMT2AMEN1GAA
SCHEMBL5174459 0.76 MAPK14 (0.71) MAPTDHODHLMNAPOLBMAPK13
SCHEMBL7035348 0.76 NPC1 (0.55) NPC1RAB9ASMN1; SMN2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP claimed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US claimed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US claimed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO claimed
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP disclosed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US disclosed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US disclosed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha IL1B, IL1A, NFKBIA NPC1 2436/4885RAB9A 3591/4885SMN1; SMN2 3343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.